News

8 Dec 2025

DNDi statement on COP30: Advancing health in the climate agenda

News

4 Dec 2025

Dr Javid Abdelmoneim, Datuk Dr Mahathar bin Abd Wahab, Dr Taruna Madan, Violet Naanyu, and Dr Mario Santos Moreira join the Board of Directors at DNDi

Scientific articles

2 Dec 2025

The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities

Parasites & Vectors

Press releases

27 Nov 2025

International seminar explores the development of treatments for dengue for populations not covered by vaccines

News

26 Nov 2025

DNDi statement on the approval of the Instituto Butantan’s dengue vaccine and the need for a dengue treatment

Scientific articles

25 Nov 2025

Bidirectional interaction between liposomal amphotericin B pharmacokinetics and parasite dynamics in patients with post-kala-azar dermal leishmaniasis: Potential implications for optimal dosing

Clinical Pharmacology & Therapeutics

Videos

24 Nov 2025

Interview with Dr Pauline Williams, new DNDi Scientific Advisory Committee (SAC) Chair

Scientific articles

20 Nov 2025

Leishmaniasis

Nature Reviews Disease Primers

Scientific articles

20 Nov 2025

Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants

British Journal of Clinical Pharmacology

Videos

20 Nov 2025

Beni: Surviving Sleeping Sickness

Viewpoints

20 Nov 2025

Neglecting infectious diseases is a market failure

Financial Times

News

17 Nov 2025

New DNDi report: Open science in a closed world – lessons and opportunities for securing openness and equitable access in R&D collaborations